Jim brings more than 35 years of success in global clinical research and pharma, most recently at CTI Clinical Trial & Consulting Services where he played a pivotal role in building one of the industry's leading cell and gene therapy portfolios. He’s a seasoned executive, relationship builder, and sales leader— with a track record of being a leading revenue driver while at CTI and shaping commercial strategies across the globe.

His deep network in the cell therapy ecosystem, paired with his clinical and commercial insight, makes him the perfect addition as we execute our go-to-market strategy and look toward our long-term goal of supporting clinical operations for advanced therapy companies.